Physician profile
John Byrd
NPI 1881276913
$1,962.97
in general payments reported to CMS, 2019-2025
24 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $216 · 2023: $617 · 2024: $667 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $307.77 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $225.14 | 2021-2025 | Brilinta |
| Novo Nordisk INC | $212.35 | 2023-2025 | Rybelsus, Ozempic, Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $170.73 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $148.97 | 2021-2024 | Bodyguardian, Lux-Dx Insertable Cardiac Monitor |
| Pfizer INC. | $114.18 | 2023-2025 | |
| Janssen Pharmaceuticals, INC | $104.90 | 2024 | Xarelto |
| Actelion Pharmaceuticals US, INC. | $99.86 | 2023-2024 | Opsumit, Uptravi |
| Amgen INC. | $70.16 | 2022-2024 | Repatha |
| Lexicon Pharmaceuticals, INC. | $67.93 | 2023-2024 | Inpefa |
| Kestra Medical Technology Services, INC. | $57.09 | 2025 | Assure Wcd |
| Atricure, INC. | $56.75 | 2024-2025 | Atriclip Laa Exclusion System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.58 | 2022-2023 | Ofev |
| Grifols USA, LLC | $48.00 | 2023 | Prolastin-C Liquid |
| Bayer Healthcare Pharmaceuticals INC. | $34.92 | 2023-2025 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $33.28 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $32.63 | 2022-2025 | Verquvo |
| Getinge USA Sales, LLC | $25.41 | 2024 | Cardiosave Hybrid, Type B Plug |
| Baxter Healthcare | $20.34 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Takeda Pharmaceuticals U.S.A., INC. | $20.32 | 2023 | Aralast |
| Inspire Medical Systems, INC. | $19.78 | 2024 | Inspire |
| Molnlycke Health Care US, LLC | $14.63 | 2024 | Hubs, Hibi Foot-Wall Dispenser, Hibi Foam Pump |
| Surmodics, INC. | $14.34 | 2025 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Chiesi USA, INC. | $12.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Byrd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.